A Phase III, Multicenter, Parallel-Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam Versus Vehicle in Women With Female Pattern Hair Loss
用户ZZBdUadOS9nM
1小时前
6
10
求助中
帖子自动结束时间: 2026-04-18 09:42:26
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性,不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接: https://pubmed.ncbi.nlm.nih.gov/27391639
其他信息:
PMID: 27391639
作者: Wilma Bergfeld; Ken Washenik; Valerie Callender; Paul Zhang; Carlos Quiza; ...
摘要: BACKGROUND Female pattern hair loss (FPHL) is a common hair disorder that affects millions of women. A new 5% minoxidil topical foam (MTF) formulation, which does not contain propylene glycol, has been developed.<br/>

